(VIANEWS) – The NASDAQ ended the session with Canopy Growth rising 16.61% to $7.23 on Tuesday, after two sequential sessions in a row of losses. NASDAQ slid 0.42% to $16,315.70, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today. Canopy Growth’s last close was $6.20, 71.03% under its…
(VIANEWS) – Sabre Corporation (SABR) shares experienced a sharp 17.26% gain over five sessions from EUR2.03 to EUR2.36 on Tuesday – this came after two consecutive days of losses and following an upward trend in previous sessions. Meanwhile, the NASDAQ index rose 0.25% after experiencing an initial downward trend in previous session; Sabre Corporation closed…
(VIANEWS) – FibroGen (NASDAQ: FGEN) experienced an unprecedented 30.98% surge over the past 21 sessions, rising from EUR1.98 on February 28th to EUR2.59 at 12:57 EST Tuesday at 12:57, marking five straight sessions of gains. Meanwhile, NASDAQ is also showing signs of life with its Index currently up 0.39% at EUR16,447.96; FibroGen’s last close price…
About Viking Therapeutics Viking Therapeutics is a clinical-stage biopharmaceutical company, focused on the creation of innovative treatments for metabolic and endocrine conditions. VK2809, their lead drug candidate, is a tissue and receptor subtype selective agonist of thyroid hormone receptor beta currently in Phase IIb clinical trials for treating nonalcoholic steatohepatitis and nonalcoholic fatty liver disease…
(VIANEWS) – The NASDAQ opens in less than hour and Viking Therapeutics‘s pre-market value is already 14.54% up. Viking Therapeutics’s last close was $69.19, 30.4% under its 52-week high of $99.41. The last session, NASDAQ finished with Viking Therapeutics (VKTX) dropping 0.52% to $69.19. NASDAQ slid 0.27% to $16,384.47, following the last session’s downward trend…
(VIANEWS) – The NASDAQ opens in less than hour and TherapeuticsMD‘s pre-market value is already 4.8% up. TherapeuticsMD’s last close was $2.29, 51.48% under its 52-week high of $4.72. The last session, NASDAQ finished with TherapeuticsMD (TXMD) sliding 0% to $2.29. NASDAQ dropped 0.27% to $16,384.47, following the last session’s downward trend on what was…
(VIANEWS) – The NASDAQ opens in less than hour and iShares Core MSCI Total‘s pre-market value is already 5.47% down. The last session, NASDAQ finished with iShares Core MSCI Total (IXUS) falling 0.09% to $67.51. NASDAQ fell 0.27% to $16,384.47, following the last session’s downward trend on what was a somewhat negative trend trading session….
About Cronos Group Cronos Group Inc. is an industry-leading cannabinoid company, specializing in the cultivation, production and marketing of premium cannabis products in Canada, Israel and Germany. Their offerings include dried flower, pre-rolls, oils vaporizers edibles tinctures from their Spinach Lord Jones PEACE NATURALS brands as well as hemp tinctures. Established in 2012 and headquartered…
(VIANEWS) – Pacific Biosciences of California (NASDAQ: PACB) stock prices fell 34.72% over 21 sessions from EUR5.53 to EUR3.61, from February 29th to March 14th. This decline occurred even as the wider NASDAQ market, dropped only 0.27% to EUR16,384.47; its stock now trading 75.19% below its 52-week high of EUR14.55. About Pacific Biosciences of California…
(VIANEWS) – Over the last five trading sessions, shares of Aspen Group (NASDAQ: ASPU) have experienced an extraordinary upsurge – increasing by 16.44%. Opening at EUR0.22 last Friday morning and rising steadily throughout the day on Tuesday to reach EUR0.26 at 09:31 EST at 09:31, it marked five consecutive sessions of gains for Aspen Group…
